Importance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epidemic Season in Poland

Lidia B. Brydak; Karol Szymański; Katarzyna Kondratiuk; Anna Poznańska; Adam Kolondra; Ewelina Hallmann

doi:10.12659/MSM.936495

20 May 2022: Clinical Research

Importance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epidemic Season in Poland

Lidia B. Brydak ^1ADEFG , Karol Szymański ^1BF , Katarzyna Kondratiuk ^1BF , Anna Poznańska ^2CDE , Adam Kolondra ^1B , Ewelina Hallmann ^1BDEF*

DOI: 10.12659/MSM.936495

Med Sci Monit 2022; 28:e936495

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 4 Response rate for anti-B/Colorado/06/2017 (B/Victoria lineage) antibodies by age of respondents and their influenza vaccination status in the 2019/2020 season.

Back to the Article

Importance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epidemic Season in Poland

Your Privacy